July 2018
Volume 59, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2018
AAV 44.9- a novel capsid that efficiently transduces photoreceptors and retinal pigment epithelium
Author Affiliations & Notes
  • Shreyasi Choudhury
    Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, United States
  • Russell Mellen
    Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, United States
  • Kevin Mccullough
    Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, United States
  • James Peterson
    Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, United States
  • Diego Fajardo
    Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, United States
  • John Chiorini
    National Institutes of Health/Nidcr, Bethesda, Maryland, United States
  • Sanford L Boye
    Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, United States
  • Shannon Elizabeth Boye
    Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, United States
  • Footnotes
    Commercial Relationships   Shreyasi Choudhury, None; Russell Mellen, None; Kevin Mccullough, None; James Peterson, None; Diego Fajardo, None; John Chiorini, None; Sanford Boye, None; Shannon Boye, None
  • Footnotes
    Support  R01 EY024280, Z01-DE00695
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4536. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shreyasi Choudhury, Russell Mellen, Kevin Mccullough, James Peterson, Diego Fajardo, John Chiorini, Sanford L Boye, Shannon Elizabeth Boye; AAV 44.9- a novel capsid that efficiently transduces photoreceptors and retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4536.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Adeno-associated virus (AAV) has become the vector of choice for targeting therapeutic genes to the retina. Both naturally occurring and synthetic AAVs have been identified that display retinal tropism. Recently, a novel AAV capsid, 44.9, was isolated as a contaminant of a laboratory stock of adenovirus. The purpose of our study was to evaluate its transduction of ocular cell lines and mouse retina following intravitreal (Ivt) or subretinal (SR) injection with emphasis on photoreceptor transduction efficiency.

Methods : A self-complementary AAV construct containing the smCBA promoter driving an mCherry reporter was packaged into AAV44.9, AAV5 or AAV8(Y733F). ARPE19 (human RPE) and 661W (mouse cone) cell lines were infected and transduction evaluated by flow cytometry. Vectors were also Ivt and SR injected into Nrl-GFP mice that constitutively express GFP in rods. Transduction was qualitatively evaluated by fluorescent fundoscopy. Transduction of rods and non-rod cells (all other neural retina) was quantified by flow cytometry and vector tropism was determined by microscopy of retinal sections. Next, we evaluated whether addition of a tyrosine to phenylalanine (Y-F) mutation at a position shown to improve transduction efficiencies of other AAV capsids enhanced AAV44.9. Finally, we asked whether AAV44.9 could effectively transduce cones by SR injecting WT mice with AAV44.9 containing the cone preferential IRBP/GNAT2 promoter and a GFP reporter.

Results : Results: AAV44.9 vectors packaged with high efficiency. Transduction of ocular cell lines was achievable, however efficiency was low. Ivt injection resulted in limited retinal transduction, similar to that observed for AAV5 and AAV8(Y733F). Subretinal injection resulted in extensive transduction that was primarily restricted to photoreceptors and RPE. In Nrl-GFP mice SR injected with AAV44.9, the percent of transduced rods (GFP and mCherry positive cells) was higher (63.5%) than in mice injected with benchmark vectors AAV5 (40.8%) and AAV8(Y733F) (53.9%). Surprisingly, the addition of the Y733F mutation to AAV44.9 did not improve transduction efficiency in vitro or in vivo. Analysis of cone transduction is underway.

Conclusions : AAV44.9 is a promising candidate for photoreceptor- targeted gene therapies. It remains to be seen whether additional improvements through rational design are achievable.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×